Replies to post #29727 on Biotech Values

[ThomasS]

"Albuferon requires less frequent dosing, which may improve its tolerability and efficacy."
I have suspicions about the tolerability part...short term side-effects are irrelevant; it is the longer-term side effects which matter. I mean the ones which commence @ 2-4 weeks after initial dosing.

As for better efficacy, I am a believer.

[mskatiescarletohara]

Congrats to HGSI!!!! It certainly does appear NVS is ramping up it's anti-viral arsenal and since they are marketing IDIX's Hep B abroad, along with their HEP C candidate, I would not be surprised to see NVS begin making strategic moves in treating HIV, another market that is to double in the next 5 years. It appears NVS may actually be contemplating a new SOC regimen as one is needed so desperately, VRTX, hmmmm now that would be interesting if NVS licensed VX-950.

katie...